Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats

Food and Chemical Toxicology

Volumn 60, Issue , 2013, Pages 160-167

  Babacanoglu, C ^a   Yildirim, N ^a   Sadi, G ^b   Pektas, M B ^a   Akar, F ^a  

^a GAZI UNIVERSITY   (Turkey)

^b KARAMANOGLU MEHMETBEY UNIVERSITY   (Turkey)

Author keywords

Endothelin; ENOS; High fructose corn syrup; IRS 1; Resveratrol; Vascular insulin resistance

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FRUCTOSE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; NITRIC OXIDE; RESVERATROL; SUCROSE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; HIGH FRUCTOSE CORN SYRUP INDUCED VASCULAR INSULIN RESISTANCE; INSULIN RESISTANCE; MALE; METABOLIC PARAMETERS; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ENDOTHELIN; ENOS; HIGH-FRUCTOSE CORN SYRUP; IRS-1; RESVERATROL; VASCULAR INSULIN RESISTANCE;

ANIMALS; BODY WEIGHT; CHOLESTEROL, VLDL; ENDOTHELIN-1; FRUCTOSE; GENE EXPRESSION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; RNA, MESSENGER; STILBENES; SWEETENING AGENTS; TRIGLYCERIDES;

EID: 84882574019     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.07.026     Document Type: Article

References (45)

1. Abe H., Yamada N., Kamata K., Kuwaki T., Shimada M., Osuga J., Shionoiri F., Yahagi N., Kadowaki T., Tamemoto H., Ishibashi S., Yazaki Y., Makuuchi M. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J. Clin. Invest. 1998, 101(8):1784-1788.
2. Akar F., Pektas M.B., Tufan C., Soylemez S., Sepici A., Ulus A.T., Gokalp B., Ozturk K., Surucu H.S. Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits. Cardiovasc. Drugs Ther. 2011, 25:119-131.
3. Akar F., Uludag O., Aydin A., Aytekin Y.A., Elbeg S., Tuzcu M., Sahin K. High-fructose corn syrup causes vascular dysfunction associated with metabolic disturbance in rats: protective effect of resveratrol. Food Chem. Toxicol. 2012, 50:2135-2141.
4. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
5. Bocarsly M.E., Powell E.S., Avena N.M., Hoebel B.G. High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol. Biochem. Behav. 2010, 97:101-106.
6. Centeno-Baez C., Dallaire P., Marette A. Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E922-E930.
7. Collison K.S., Saleh S.M., Bakheet R.H., Al-Rabiah R.K., InglisA L., Makhoul N.J., Maqbool Z.M., Zaidi M.Z., Al-Johi M.A., Al-Mohanna F.A. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. Obesity 2009, 17:2003-2013.
8. Crandall J.P., Oram V., Trandafirescu G., Reid M., Kishore P., Hawkins M., Cohen H.W., Barzilai N. Pilot study of resveratrol in older adults with impaired glucose tolerance, J. Gerontol. A Biol. Sci. Med. Sci. 2012, Jan, 4.
9. Deng J.-Y., Hsieh P.-S., Huang J.-P., Lu L.-S., Hung L.M. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and independent pathways. Diabetes 2008, 57:1814-1823.
10. Figlewicz D.P., Ioannou G., Bennett Jay J., Kittleson S., Savard C., Roth C.L. Effect of moderate intake of sweeteners on metabolic health in the rat. Physiol. Behav. 2009, 98:618-624.
11. Frojdo S., Cozzone D., Vidal H., Pirola L. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem. J. 2007, 406:511-518.
12. Frojdo S., Durand C., Molin L., Carey A.L., El-Osta A., Kingwell B.A., Febbraio M.A., Solari F., Vidal H., Pirola L. Phosphoinositide 3-kinase as a novel functional target for the regulation of then insulin signaling pathway by SIRT1. Mol. Cell. Endocr. 2011, 335:166-176.
13. Fujimoto M., Shimizu N., Kunii K., Martyn J.A., Ueki K., Kaneki M. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 2005, 54:1340-1348.
14. Jones H.F., Butler R.N., Brooks D.A. Intestinal fructose transport and malabsorption in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G202-G206.
15. Juan C.C., Fang V.S., Hsu Y.P., Huang Y.J., Hsia D.B., Yu P.C., Kwok C.F., Ho L.T. Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model. J. Hypertens. 1998, 16:1775-1782.
16. Katakam P.V.G., Pollock J.S., Pollock D.M., Ujhelyi M.R., Miller A.W. Enhanced endothelin-1 response in small mesenteric arteries of insulin resistant rats is due to receptor over expression. Am. J. Physiol. 2001, 280:H522-H527.
17. Koh K.K., Han S.H., Quon M.J. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J. Am. Coll. Cardiol. 2005, 46:1978-1985.
18. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
19. Lee J.H., Song M.Y., Song E.K., Kim E.K., Moon W.S., Han M.K., Park J.W., Kwon K.B., Park B.H. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009, 58:344-351.
20. Light H.R., Tsanzi E., Gigliotti J., Morgan K., Tou J.C. The type of caloric sweetener added to water influences weight gain, fat mass, and reproduction in growing Sprague-Dawley female rats. Exp. Biol. Med. 2009, 234:651-661.
21. Lowry O., Roserbrough N., Farr A., Randall R. Protein measurement with folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
22. Marriott B.P., Cole N., Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J. Nutr. 2009, 139:1228-1235.
23. Miller A.W., Tulbert C., Puskar M., Busija D.W. Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance. Hypertension 2002, 40:78-82.
24. Muniyappa R., Montagnani M., Koh K.K., Quon M.J. Cardiovascular actions of insulin. Endocr. Rev. 2007, 28:463-491.
25. Muniyappa R., Sowers J.R. Role of insulin resistance in endothelial dysfunction. Rev. Endocr. Metab. Disord. 2013, 14(1):5-12.
26. Nagareddy P.R., Xia Z., McNeill J.H., MacLeod K.M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2144-H2152.
27. Orimo M., Minamino T., Miyauchi H., Tateno K., Okada S., Moriya J., Komuro I. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 2009, 29:889-894.
28. Pasarin M., Abraldes J.G., Rodriguez-Vilarrupla A., La Mura V., Garcia-Pagan J.C., Bosch J. Insulin resistance and liver microcirculation in a rat model of early NAFLD. J. Hepatol. 2011, 55:1095-1102.
29. Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., Swindell W.R., Kamara D., Minor R.K., Perez E., Jamieson H.A., Zhang Y., Dunn S.R., Sharma K., Pleshko N., Woollett L.A., Csiszar A., Ikeno Y., Le Couteur D., Elliott P.J., Becker K.G., Navas P., Ingram D.K., Wolf N.S., Ungvari Z., Sinclair D.A., de Cabo R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending lifespan. Cell Metab. 2008, 8:157-168.
30. Sanchez-Lozada L.G., Tapia E., Jimenez A., Bautista P., Cristobal M., Nepomuceno T., Soto V., Avila-Casado C., Nakagawa T., Johnson R.J., Herrera-Acosta J., Franco M. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur. J. Nutr. 2010, 49:1-9.
31. Sheludiakova A., Rooney K., Boakes R.A. Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat. Eur. J. Nutr. 2012, 10.1007/s00394-011-0228-x.
32. Tappy L., Le K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90:23-46.
33. Tran L.T., Yuen V.G., McNeill J.H. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol. Cell. Biochem. 2009, 332:145-159.
34. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76(9):4350-4354.
35. Ventura E.E., Davis J.N., Goran M.I. Sugar content of popular sweetened beverages based on objective laboratory analysis: focus on fructose content. Obesity 2011, 19:868-884.
36. Verma S., Bhanot S., Yao L., McNeill J.H. Vascular insulin resistance in fructose hypertensive rats. Eur. J. Pharmacol. 1997, 322:R1-R2.
37. Vicent D., Ilany J., Kondo T., Naruse K., Fisher S.J., Kisanuki Y.Y., Bursell S., Yanagisawa M., King G.L., Kahn C.R. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest. 2003, 111:1373-1380.
38. Wang Y., Cheng K.K., Lam K.S., Wu D., Wang Y., Huang Y., Vanhoutte P.M., Sweeney G., Li Y., Xu A. APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice. Diabetes 2011, 60:3044-3054.
39. Xu X., Zhao C.X., Wang L., Tu L., Fang X., Zheng C., Edin M.L., Zeldin D.C., Wang D.W. Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes 2010, 59:997-1005.
40. Xu X., Tu L., Wang L., Fang X., Wang D.W. CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats. Cardiovasc. Diabetol. 2011, 10:114.
41. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., Quon M.J. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101:1539-1545.
42. Zhang H., Zhang J., Ungvari Z., Zhang C. Resveratrol improves endothelial function. Role of TNF and vascular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1164-1171.
43. Zhang J. Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem. J. 2006, 397:519-527.
44. Zhang J. The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J. Biol. Chem. 2007, 282(47):34356-34364.
45. Zhao C.X., Xu X., Cui Y., Wang P., Wei X., Yang S., Edin M.L., Zeldin D.C., Wang D.W. Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. J. Pharmacol. Exp. Ther. 2009, 328(2):610-620.